Philippines Orders Recall Of Novartis Prexige Because Of Liver Damage
This article was originally published in PharmAsia News
Executive Summary
Philippine authorities ordered the Novartis anti-inflammatory painkiller Prexige (lumiracoxib) recalled because of an increased risk of liver damage. The Cox-2 selective inhibitor for treating osteoarthritis and dysmenorrhia has been withdrawn recently in several other countries. The Philippines Bureau of Food and Drugs said it had determined the drug could cause liver damage. (Click here for more